Loading...
Loading...
Among the 9 tracked institutional investors we monitor, CPRX (CATALYST PHARMACEUTICALS INC) is held with a combined value of $963.15M across 39,383,228 shares. The largest holder is BlackRock, Inc. with a position worth $464.86M (0.01% of their portfolio). 2 funds opened new positions in the most recent quarter. 2 funds increased their holdings. 5 funds reduced their position.
Total Institutional Value
$963.15M
Total Shares Held
39,383,228
Institutional Holders
9
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $464.86M | 0.01% | +0.8% |
| 2 | VANGUARD GROUP INC | $196.81M | 0.00% | New |
| 3 | STATE STREET CORP | $169.93M | 0.01% | -0.6% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $58.12M | 0.09% | -11.4% |
| 5 | Fundsmith LLP | $20.92M | 0.16% | -74.9% |
| 6 | MILLENNIUM MANAGEMENT LLC | $19.49M | 0.01% | -20.8% |
| 7 | CITADEL ADVISORS LLC | $15.63M | 0.00% | +70.8% |
| 8 | Point72 Asset Management, L.P. | $10.54M | 0.01% | New |
| 9 | FMR LLC | $6.85M | 0.00% | -19.5% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of CPRX with a position worth $464.86M, representing 0.01% of their portfolio. In total, 9 institutional investors hold CPRX with a combined value of $963.15M.
In the most recent quarter, 2 funds opened a new position in CPRX. Additionally, 2 increased their holdings and 5 reduced their positions.
Institutional investors hold $963.15M worth of CPRX stock across 9 positions. The largest institutional holder is BlackRock, Inc. with $464.86M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CPRX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CPRX positions.